{"id":470872,"date":"2025-10-17T21:19:14","date_gmt":"2025-10-17T21:19:14","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/470872\/"},"modified":"2025-10-17T21:19:14","modified_gmt":"2025-10-17T21:19:14","slug":"les-medicaments-antiobesite-pourraient-bien-jouer-un-role-contre-lalcoolisme","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/470872\/","title":{"rendered":"Les m\u00e9dicaments antiob\u00e9sit\u00e9 pourraient bien jouer un r\u00f4le contre l\u2019alcoolisme"},"content":{"rendered":"<p>    Selon ces travaux, les agonistes du GLP-1 \u00ab ralentissent la vitesse \u00e0 laquelle l\u2019alcool entre dans le sang, ce qui ralentit aussi ses effets sur le cerveau\u00a0\u00bb.<br \/>\n                pavel siamionov \/ stock.adobe.com<\/p>\n<p>\n    <strong>D\u00c9CRYPTAGE &#8211; <\/strong>Les analogues du GLP-1, vant\u00e9s aujourd\u2019hui pour leurs effets sur l\u2019ob\u00e9sit\u00e9, ralentissent aussi l\u2019absorption d\u2019alcool dans le sang et ainsi la sensation d\u2019\u00e9bri\u00e9t\u00e9. Avec, \u00e0 terme, un potentiel effet sur l\u2019addiction \u00e0 l\u2019alcool, selon une nouvelle \u00e9tude.<\/p>\n<p class=\"fig-paragraph\"><a href=\"http:\/\/sante.lefigaro.fr\/medecine\/ozempic-victoza-les-nouveaux-antidiabetiques-confirment-leur-efficacite-bien-au-dela-du-diabete-20250122\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\" rel=\"nofollow noopener\" target=\"_blank\">Ozempic, Wegovy, Victoza\u2026<\/a>\u00a0Ces m\u00e9dicaments, initialement utilis\u00e9s pour traiter le diab\u00e8te de type\u00a02, ont d\u00e9sormais prouv\u00e9 leurs\u00a0<a href=\"http:\/\/sante.lefigaro.fr\/medecine\/on-pense-avoir-compris-d-ou-vient-l-efficacite-des-traitements-anti-obesite-20240703\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\" rel=\"nofollow noopener\" target=\"_blank\">spectaculaires effets dans le traitement de l\u2019ob\u00e9sit\u00e9<\/a>. Tous font partie des analogues du GLP-1, une hormone agissant sur la s\u00e9cr\u00e9tion d\u2019insuline et, plus largement, la sensation de sati\u00e9t\u00e9. Or, plusieurs \u00e9tudes scientifiques ont r\u00e9v\u00e9l\u00e9 qu\u2019ils\u00a0<a href=\"http:\/\/sante.lefigaro.fr\/medecine\/d-alzheimer-aux-addictions-les-nouveaux-medicaments-anti-obesite-deviendront-ils-des-traitements-a-tout-faire-20241024\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\" rel=\"nofollow noopener\" target=\"_blank\">pourraient avoir d\u2019autres effets b\u00e9n\u00e9fiques<\/a>, dont un sur l\u2019addiction \u00e0 l\u2019alcool. Une \u00e9tude publi\u00e9e ce mercredi dans la revue Scientific Reports, consolide cette hypoth\u00e8se.<\/p>\n<p class=\"fig-paragraph\">Selon ces travaux, men\u00e9s par le Fralin Biomedical Research Institute de Virginia Tech (\u00c9tats-Unis), les analogues du GLP-1 \u00ab\u00a0ralentissent la vitesse \u00e0 laquelle l\u2019alcool entre dans le sang, ce qui ralentit aussi ses effets sur le cerveau\u00a0\u00bb. Or, la vitesse d\u2019absorption est d\u00e9terminante dans l\u2019effet d\u2019\u00e9bri\u00e9t\u00e9. Un shooter de vodka, par exemple, contient la m\u00eame quantit\u00e9 d\u2019alcool qu\u2019un demi de bi\u00e8re ou un verre de vin. Mais le shot est g\u00e9n\u00e9ralement pris en\u2026<\/p>\n<p class=\"fig-premium-paywall__infos\">\n        Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s.        Il vous reste 85% \u00e0 d\u00e9couvrir.\n    <\/p>\n<p>                <img  data- alt=\"Le Figaro\" class=\"fig-img--complete fig-img\"\/><\/p>\n<p class=\"fig-premium-paywall__title\">Vous avez envie de lire la suite ?<\/p>\n<p class=\"fig-premium-paywall__subtitle\">D\u00e9bloquez tous les articles imm\u00e9diatement.<\/p>\n<p class=\"fig-premium-paywall__connect\">\n                D\u00e9j\u00e0 abonn\u00e9\u00a0?                <a class=\"fig-premium-paywall__connect-link\" href=\"https:\/\/connect.lefigaro.fr\/login?client=sante_web&amp;type=main&amp;redirect_uri=https%3A%2F%2Fsante.lefigaro.fr%2Fmedecine%2Fles-medicaments-anti-obesite-pourraient-bien-jouer-un-role-contre-l-alcoolisme-20251017\" data-js-gtm=\"{&quot;customCategorie&quot;: &quot;conversion&quot;, &quot;customAction&quot;: &quot;before_Landing_Connexion_paywall_auto&quot;, &quot;customLabel&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMGFhYTUxLWMzNDEtNjdmNi1iNzNhLTk5MmMwOWJjMTQ5N19fQXJ0aWNsZQ==_Les m\u00e9dicaments antiob\u00e9sit\u00e9 pourraient bien jouer un r\u00f4le contre l\u2019alcoolisme_459&quot;, &quot;customIDSPE&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMGFhYTUxLWMzNDEtNjdmNi1iNzNhLTk5MmMwOWJjMTQ5N19fQXJ0aWNsZQ==&quot;, &quot;event&quot;: &quot;customEventSPE&quot;}\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n                    Connectez-vous<br \/>\n                <\/a>\n            <\/p>\n","protected":false},"excerpt":{"rendered":"Selon ces travaux, les agonistes du GLP-1 \u00ab ralentissent la vitesse \u00e0 laquelle l\u2019alcool entre dans le sang,&hellip;\n","protected":false},"author":2,"featured_media":470873,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[5702,1011,27,72,233,71],"class_list":{"0":"post-470872","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-alcool","9":"tag-fr","10":"tag-france","11":"tag-health","12":"tag-obesite","13":"tag-sante"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115391598846232891","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/470872","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=470872"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/470872\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/470873"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=470872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=470872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=470872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}